CS logo
small CS logo
Retina Associates of Sarasota

Sarasota, Florida, United States
Ophthalmologist in South Gate Ridge, Florida
3920 Bee Ridge Rd Building D, Sarasota, FL 34233

About Retina Associates of Sarasota


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Retina Associates of Sarasota


During the past decade, Retina Associates of Sarasota conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of Sarasota" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Retina Associates of Sarasota


According to Clinical.Site data, the most researched conditions in "Retina Associates of Sarasota" are "Proliferative Diabetic Retinopathy" (3 trials), "Vitreous Hemorrhage" (2 trials), "Diabetic Macular Edema" (1 trials), "Full-thickness Macular Holes (MH)" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Retina Associates of Sarasota" in a lesser frequency.

Clinical Trials Intervention Types at Retina Associates of Sarasota


Most popular intervention types in "Retina Associates of Sarasota" are "Drug" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "0.5-mg Ranibizumab" (1 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred panretinal photocoagulation" (1 trials) and "Intraocular gas (C3F8)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Retina Associates of Sarasota


The vast majority of trials in "Retina Associates of Sarasota" are 7 trials for "All" genders.

Clinical Trials Status at Retina Associates of Sarasota


Currently, there are NaN active trials in "Retina Associates of Sarasota". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Retina Associates of Sarasota, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Retina Associates of Sarasota, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".